Xiaobin Hou

451 total citations
22 papers, 305 citations indexed

About

Xiaobin Hou is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xiaobin Hou has authored 22 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Xiaobin Hou's work include Esophageal Cancer Research and Treatment (7 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Xiaobin Hou is often cited by papers focused on Esophageal Cancer Research and Treatment (7 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Gastric Cancer Management and Outcomes (4 papers). Xiaobin Hou collaborates with scholars based in China, Thailand and United States. Xiaobin Hou's co-authors include Zhipeng Ren, Zhiqiang Xue, Xiangyang Chu, Weian Song, Bo Wang, Jiaxin Wen, Guoliang Zhang, Tinghui Li, Bo Wang and Lunxu Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Oncogene and American Journal of Roentgenology.

In The Last Decade

Xiaobin Hou

22 papers receiving 302 citations

Peers

Xiaobin Hou
Wei Zuo China
Hugh Luk United States
Yuqi Meng China
Angelika Brekman United States
Debayan Mukherjee United Kingdom
Qiuyan Xu China
Xiaobin Hou
Citations per year, relative to Xiaobin Hou Xiaobin Hou (= 1×) peers Yuanjie Niu

Countries citing papers authored by Xiaobin Hou

Since Specialization
Citations

This map shows the geographic impact of Xiaobin Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Hou more than expected).

Fields of papers citing papers by Xiaobin Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobin Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Hou. The network helps show where Xiaobin Hou may publish in the future.

Co-authorship network of co-authors of Xiaobin Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobin Hou. A scholar is included among the top collaborators of Xiaobin Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobin Hou. Xiaobin Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Chao, Guoqing Zhang, Lin Wang, et al.. (2024). Spatial proteomic profiling elucidates immune determinants of neoadjuvant chemo-immunotherapy in esophageal squamous cell carcinoma. Oncogene. 43(37). 2751–2767. 14 indexed citations
2.
Chen, Wen, et al.. (2022). Aptamer-siRNA chimera and gold nanoparticle modified collagen membrane for the treatment of malignant pleural effusion. Frontiers in Bioengineering and Biotechnology. 10. 973892–973892. 4 indexed citations
3.
Guo, Fengjie, et al.. (2022). The Inhibitory Effect of Regulatory T Cells on the Intimal Hyperplasia of Tissue-Engineered Blood Vessels in Diabetic Pigs. Frontiers in Bioengineering and Biotechnology. 10. 929867–929867. 2 indexed citations
4.
Zhang, Zhendong, Xiaobin Hou, Dianzhong Luo, et al.. (2022). A New Parameter of Hip Instability in Developmental Dysplasia of the Hip (DDH): Teardrop Distance. Frontiers in Surgery. 9. 899960–899960. 3 indexed citations
5.
Zhang, Pei, Xiaobin Hou, Wei Yu, et al.. (2022). Efficacy and safety of combined treatment with pembrolizumab in patients with locally advanced or metastatic esophageal squamous cell carcinoma in the real world. Annals of Translational Medicine. 10(12). 708–708. 5 indexed citations
6.
Ren, Zhipeng, Xiaobin Hou, Zhiqiang Xue, et al.. (2021). The relationship between the number of circulating tumor cells and the prognosis in patients with esophageal squamous cell carcinoma. Journal of Gastrointestinal Oncology. 12(4). 1265–1276. 2 indexed citations
7.
Hou, Xiaobin, et al.. (2021). Meta-analysis on the association between knee extensor strength and structural changes of knee osteoarthritis. Clinical Rheumatology. 40(9). 3511–3521. 6 indexed citations
9.
Hou, Xiaobin, et al.. (2020). Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma. World Journal of Clinical Cases. 8(24). 6315–6321. 7 indexed citations
10.
Ren, Zhipeng, et al.. (2018). Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer. Cancer Management and Research. Volume 10. 6143–6156. 29 indexed citations
11.
Hou, Xiaobin, Zhipeng Ren, Bo Yang, & Yang Liu. (2017). Comparison of short-term therapeutic efficacy between minimally invasive Ivor-Lewis esophagectomy and Mckeown esophagectomy for esophageal cancer. Biomedical Research-tokyo. 28(12). 5321–5326. 3 indexed citations
12.
Hou, Xiaobin, Jiaxin Wen, Zhipeng Ren, & Guoliang Zhang. (2017). Non-coding RNAs: new biomarkers and therapeutic targets for esophageal cancer. Oncotarget. 8(26). 43571–43578. 45 indexed citations
14.
Hou, Xiaobin, et al.. (2016). Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 24(4). 247–253. 4 indexed citations
15.
Li, Tinghui, Xiaobin Hou, Hong Deng, et al.. (2015). Liposomal hypocrellin B as a potential photosensitizer for age-related macular degeneration: pharmacokinetics, photodynamic efficacy, and skin phototoxicity in vivo. Photochemical & Photobiological Sciences. 14(5). 972–981. 25 indexed citations
16.
Chu, Xiangyang, et al.. (2011). Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: A single center analysis. Cancer Biology & Therapy. 11(12). 995–1000. 70 indexed citations
17.
Chu, Xiangyang, et al.. (2011). [Combination of single-port thoracoscopy and laparoscopy for the treatment of esophageal carcinoma: report of 6 cases].. PubMed. 14(9). 689–91. 1 indexed citations
18.
Chu, Xiangyang, et al.. (2010). [Primary report of lobectomy with single utility port complete video-assisted thoracoscopic surgery].. SHILAP Revista de lepidopterología. 13(1). 19–21. 8 indexed citations
19.
Ren, Xiaolong, Ruiling Yan, Ying Zheng, et al.. (2010). Biliary cystadenocarcinoma diagnosed with real-time contrast-enhanced ultrasonography: report of a case with diagnostic features.. PubMed. 16(1). 131–5. 10 indexed citations
20.
Ren, Fangyuan, et al.. (2009). Clinical and Imaging Features in 16 Infants Exposed to Food Contaminated with Melamine and Cyanuric Acid. American Journal of Roentgenology. 192(3). 707–710. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026